Ypsomed Holding AG (YPHDF)
OTCMKTS · Delayed Price · Currency is USD
374.82
-18.65 (-4.74%)
At close: Feb 5, 2026
Ypsomed Holding AG Employees
Ypsomed Holding AG had 2,000 employees as of September 30, 2025. The number of employees decreased by 644 or -24.36% since the number was reported on March 31, 2025.
Employees
2,000
Change
-644
Growth
-24.36%
Revenue / Employee
$493,835
Profits / Employee
$121,647
Market Cap
5.30B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 2,000 | -644 | -24.36% |
| Mar 31, 2025 | 2,644 | 348 | 15.16% |
| Mar 31, 2024 | 2,296 | 237 | 11.51% |
| Mar 31, 2023 | 2,059 | 136 | 7.07% |
| Mar 31, 2022 | 1,923 | 186 | 10.71% |
| Mar 31, 2021 | 1,737 | 110 | 6.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Meihua International Medical Technologies | 619 |
| Encision | 24 |
| Yubo International Biotech | 18 |
| Reflect Scientific | 8 |
| Ozop Energy Solutions | 7 |
| Standard Dental Labs | 3 |
Ypsomed Holding AG News
- 3 months ago - Ypsomed Holding AG (YPHDF) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Ypsomed Holding AG 2026 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Ypsomed Holding AG (XSWX:YPSN) (H1 2026) Earnings Call Highlights: Strong Growth in Delivery ... - GuruFocus
- 3 months ago - Half Year 2026 Ypsomed Holding AG Earnings Call Transcript - GuruFocus
- 4 months ago - Ypsomed To Establish Production Plant In US With CHF 200 Mln First Phase Investment - Nasdaq
- 4 months ago - Ypsomed Holding AG (YPHDF) Analyst/Investor Day - Slideshow - Seeking Alpha
- 1 year ago - Novo Nordisk (NVO) Partners with Ypsomed for Next-Gen Obesity Drug Delivery - GuruFocus
- 1 year ago - Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens - Seeking Alpha